Jump Financial’s Praxis Precision Medicines PRAX Stock Holding History

Jump Financial’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$877K	Buy	+2,621	New	+$830K	0.01%	1245
2025 Q1	–	Sell	-11,188	Closed	-$861K	–	1927
2024 Q4	$861K	Buy	+11,188	New	+$810K	0.02%	817
2024 Q3	–	Sell	-14,321	Closed	-$592K	–	2024
2024 Q2	$592K	Buy	14,321 +10,872	+315%	+$514K	0.01%	1066
2024 Q1	$210K	Buy	+3,449	New	+$155K	0.01%	1657
2023 Q4	–	Sell	-2,177	Closed	-$55.8K	–	2144
2023 Q3	$55.8K	Buy	+2,177	New	+$41.2K	﹤0.01%	1740
2022 Q4	–	Sell	-3,487	Closed	-$119K	–	1941
2022 Q3	$119K	Buy	3,487 +627	+22%	+$31.2K	﹤0.01%	1428
2022 Q2	$105K	Buy	2,860 +1,967	+220%	+$210K	﹤0.01%	1439
2022 Q1	$137K	Buy	+893	New	+$183K	0.01%	1376

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jump Financial's PRAX Position: Q2 2026 in Review

Jump Financial opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 2,621 shares worth $877K. The stake represents 0.01% of the portfolio and ranks #1245 among its holdings. This is a return to the name: Jump Financial previously reported a position in PRAX as recently as Q4 2024.

Jump Financial first reported a position in PRAX in Q1 2022 and has held it in 8 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Jump Financial held 2,621 shares of Praxis Precision Medicines worth $877K as of Q2 2026.
Praxis Precision Medicines was a new Jump Financial position in Q2 2026.
Praxis Precision Medicines made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1245 holding.
Jump Financial first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 8 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.